Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 10/20 | 0.59 |
| ▸ | MTNR1B | P49286 | 9/20 | 0.59 |
| ▸ | NQO2 | P16083 | 4/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8575769 | 0.84 | MTNR1A (0.64) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8575772 | 0.84 | MTNR1A (0.64) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8888224 | 0.84 | MTNR1A (0.56) | MTNR1AMTNR1BNQO2TRPV1HTT | |
| SCHEMBL8431981 | 0.83 | MTNR1A (0.63) | MTNR1AMTNR1BNQO2TRPV1 | |
| SCHEMBL8606216 | 0.83 | MTNR1A (0.63) | MTNR1AMTNR1BNQO2TRPV1 | |
| SCHEMBL8887000 | 0.82 | MTNR1A (0.88) | MTNR1AMTNR1BNQO2TRPV1 | |
| SCHEMBL8887067 | 0.82 | MTNR1A (0.73) | MTNR1AMTNR1BNQO2TRPV1 | |
| SCHEMBL8888114 | 0.81 | MTNR1A (0.58) | MTNR1AMTNR1BNQO2TRPV1HTT | |
| SCHEMBL8887165 | 0.79 | MTNR1A (0.58) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL9568037 | 0.79 | CNR1 (0.46) | MTNR1AMTNR1BTRPV1HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5661186-A | MELATONERGIC EFFECT; CENTRAL NERVOUS SYSTEM DISODERS | BRISTOL-MYERS SQUIBB CO. (US) | 1997-08-26 | — | — | US | claimed |
| EP-0728738-A1 | Tetralinyl- and indanyl-ethylamides having melatonergic activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-08-28 | — | — | EP | claimed |
| US-5661186-A | MELATONERGIC EFFECT; CENTRAL NERVOUS SYSTEM DISODERS | BRISTOL-MYERS SQUIBB CO. (US) | 1997-08-26 | — | — | US | disclosed |
| EP-0728738-A1 | Tetralinyl- and indanyl-ethylamides having melatonergic activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-08-28 | — | — | EP | disclosed |